Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

1347326

registered interest
date	15/07/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Travel: Coronavirus
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that UK citizens who have received the AstraZeneca vaccine produced in India are able to participate in travel to the EU without having to quarantine.
tabling member constituency	Hampstead and Kilburn
tabling member printed	Tulip Siddiq
uin	33999
answer	answer is ministerial correction date of answer 22/07/2021 answer text <p>All University of Oxford/AstraZeneca doses manufactured by the Serum Institute of India and administered in the United Kingdom have been approved by the Medicines and Healthcare products Regulatory Agency, and are known commercially as ‘Vaxzevria’. The European Medicines Agency has authorised the Vaxzevria vaccine and as a result is recognised by the European Union.</p><p>The EU recently set out their Green Pass initiative for double vaccinated EU citizens and the minimum criteria for the vaccines Member States should accept. This includes the University of Oxford/AstraZeneca vaccine and all our other currently deployed vaccines. However, it is for individual Member States to determine the vaccine criteria accepted at their borders.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 22/07/2021 14:44:53 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4518 label Biography information for Tulip Siddiq

1308078

registered interest
date	12/04/2021
answering body	Department for Business, Energy and Industrial Strategy
answering dept id	201
answering dept short name	Business, Energy and Industrial Strategy
answering dept sort name	Business, Energy and Industrial Strategy
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Business, Energy and Industrial Strategy, what steps his Department has taken to procure doses of covid-19 vaccine boosters to help deliver immunity to tackle new coronavirus variants which may have greater levels of resistance to available covid-19 vaccines.
tabling member constituency	Hampstead and Kilburn
tabling member printed	Tulip Siddiq
uin	179312
answer	answer is ministerial correction date of answer 21/04/2021 answer text <p>The Government is assessing our existing vaccine portfolio against current variants, working closely with vaccine manufacturers and Public Health England to understand the efficacy of our current vaccine portfolio against new variants. <br></p><p>The Government has also established a new partnership with the vaccine manufacturer, CureVac, to rapidly develop new vaccines in response to new Covid-19 variants should this be needed. The new agreement will utilise UK expertise on genomics and virus sequencing to allow new varieties of vaccines based on messenger RNA technology to be developed quickly against new strains of Covid-19. An initial order has been made for 50 million doses.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 21/04/2021 10:53:03 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4518 label Biography information for Tulip Siddiq

1288234

registered interest
date	22/02/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether he has made an assessment of the potential merits of adding people with long covid to the priority list for covid-19 vaccination.
tabling member constituency	Hampstead and Kilburn
tabling member printed	Tulip Siddiq
uin	156488
answer	answer is ministerial correction date of answer 08/04/2021 answer text <p>Over 25 million people across the United Kingdom have now received their first dose of a COVID-19 vaccine. The Joint Committee on Vaccination and Immunisation is monitoring the emerging evidence on ‘long’ COVID-19 and will review this as part of its considerations for the immunisation programme.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 08/04/2021 09:23:51 answering member 4113 label Biography information for Nadhim Zahawi previous answer version 85296 answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4518 label Biography information for Tulip Siddiq

1287403

registered interest
date	19/02/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether he has made an assessment of the potential merits of including people with disabilities in the priority list for covid-19 vaccination.
tabling member constituency	Hampstead and Kilburn
tabling member printed	Tulip Siddiq
uin	155273
answer	answer is ministerial correction date of answer 12/04/2021 answer text <p>The Joint Committee on Vaccination and Immunisation (JCVI) is the independent body made up of scientific and clinical experts who advise the Government on which vaccines the United Kingdom should use and provide advice on prioritisation at a population level. There is good evidence that certain underlying health conditions increase the risk of morbidity and mortality from COVID-19, therefore individuals with these underlying health conditions have been prioritised for a COVID-19 vaccination as part of phase one. These underlying health conditions do not include all disabilities. However, adults with Down’s syndrome are clinically extremely vulnerable and are included in priority group four. Those with severe and profound learning disability are in priority group six.</p><p> </p><p>On 24 February the JCVI published a clarification of their advice on vaccinating people with a learning disability. They confirmed their view that priority should be given to those with a severe and profound learning disability, but recognised concerns about coding of learning disability on general practitioner (GP) systems and supported a practical approach of inviting everyone who is on a GP Learning Disability Register for vaccination in priority group six.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 12/04/2021 14:04:29 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4518 label Biography information for Tulip Siddiq

1284085

registered interest
date	04/02/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that covid-19 vaccination centres meet required health and safety standards.
tabling member constituency	Hampstead and Kilburn
tabling member printed	Tulip Siddiq
uin	149303
answer	answer is ministerial correction date of answer 07/04/2021 answer text <p>Vaccination sites must administer the vaccine in line with the best Infection Prevention Control (IPC) procedures including social distancing, ventilation and wearing masks.</p><p>Large-scale centres are required to have an environmental risk assessment in place which is expected to cover requirements for ventilation in a pandemic when transmission and virus shedding is a significant concern.</p><p>The vaccination process, from the National Booking System to the structure and delivery in the vaccination sites, has been designed to ensure a steady throughput of people to avoid bottlenecks and overcrowding.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 07/04/2021 09:36:19 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4518 label Biography information for Tulip Siddiq

1280744

registered interest
date	26/01/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, at what stages of the covid-19 vaccination prioritisation process will (a) children’s social care workers and (b) staff in SEN school settings be offered vaccination.
tabling member constituency	Hampstead and Kilburn
tabling member printed	Tulip Siddiq
uin	143854
answer	answer is ministerial correction date of answer 02/02/2021 answer text <p>The Joint Committee on Vaccination and Immunisation (JCVI) advises that the first priorities for any COVID-19 vaccination programme should be to reduce COVID-19 mortality and protect the health and social care staff and systems. As a result, they have based their prioritisation largely on age and those with clinical risk factors aged 16 years old and above.</p><p> </p><p>In line with the JCVI’s recommendations, individuals who regularly work with clinically extremely vulnerable individuals or those who have underlying health conditions, should receive the vaccine in line with social care workers. The local authority Director of Adult Social Services should have ultimate responsibility for identifying eligible social care workers, underlined by the principle aim of achieving high rates of vaccination amongst frontline social care workers who work closely and regularly with those who are clinically vulnerable to COVID-19. In addition, if a special school staff member is identified as being in one of the other at-risk cohorts, they will be contacted by the National Health Service at the appropriate time based on the JCVI’s advice.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 02/02/2021 16:58:02 answering member 4113 label Biography information for Nadhim Zahawi previous answer version 78953 answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4518 label Biography information for Tulip Siddiq

1280746

registered interest
date	26/01/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of putting asthma sufferers who purchase asthma medicine abroad in the same priority group as clinically vulnerable asthma sufferers for the covid-19 vaccination.
tabling member constituency	Hampstead and Kilburn
tabling member printed	Tulip Siddiq
uin	143856
answer	answer is ministerial correction date of answer 18/03/2021 answer text <p>The Joint Committee on Vaccination and Immunisation, having looked at a wide range of evidence, concluded that only a subset of those with asthma are at clinically higher risk from COVID-19. This group is defined as adults with asthma who require continuous or repeated use of systemic steroids or with previous exacerbations requiring hospital admission. They will be vaccinated in priority group six. Some individuals with more severe asthma may also be included in the clinically extremely vulnerable group, in which case they will be vaccinated in priority group four.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 18/03/2021 15:17:19 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4518 label Biography information for Tulip Siddiq